Joseph P. Lucia & Associates’s Evofem Biosciences, Inc. Common Stock EVFM Stock Holding History

Joseph P. Lucia & Associates’s Portfolio EVFM Stock Details EVFM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1	Closed	–	–	525
2022 Q1	$0	Buy	+1	New	+$6	﹤0.01%	481
2021 Q4	–	Sell	-1	Closed	–	–	596
2021 Q3	$0	Hold	1	–	–	﹤0.01%	633
2021 Q2	$0	Hold	1	–	–	﹤0.01%	641
2021 Q1	$0	Hold	1	–	–	﹤0.01%	630
2020 Q4	$0	Buy	+1	New	+$36	﹤0.01%	509
2020 Q3	–	Sell	-1	Closed	–	–	490
2020 Q2	$0	Buy	+1	New	+$67	﹤0.01%	514

Other funds holding EVFM

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

FWSM

First Wilshire Securities Management Pasadena, California $444M AUM 42.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Joseph P. Lucia & Associates's EVFM Position: Q2 2022 in Review

Joseph P. Lucia & Associates sold out of Evofem Biosciences, Inc. Common Stock (EVFM) in Q2 2022, closing a stake of 1 share.

Joseph P. Lucia & Associates first reported a position in EVFM in Q2 2020 and held it in 6 quarters. The position peaked at $0 in Q1 2022. 44 funds tracked by Wall St. Rank hold EVFM as of Q2 2022.

Joseph P. Lucia & Associates reported no remaining Evofem Biosciences, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
Joseph P. Lucia & Associates sold 1 Evofem Biosciences, Inc. Common Stock share in Q2 2022.
Joseph P. Lucia & Associates first reported a position in Evofem Biosciences, Inc. Common Stock in Q2 2020 and held it in 6 quarters.
Joseph P. Lucia & Associates's Evofem Biosciences, Inc. Common Stock position peaked at $0 in Q1 2022.
44 funds tracked by Wall St. Rank held Evofem Biosciences, Inc. Common Stock as of Q2 2022.

Based on Joseph P. Lucia & Associates's 13F filing for Q2 2022, filed 26 Jul 2022.